Dr. Wassim Marwan Mchayleh, MD

Media Releases

Get to know Hematologist-Oncologist Dr. Wassim Mchayleh, who serves patients in Georgia.

Fluent in Arabic and French, Dr. Mchayleh is a board-certified hematologist-oncologist whose clinical interests include head, lung, and neck cancers. He has a strong commitment to treating each of his patients in a caring and loving environment as if they were a part of his own family.

The doctor can be found on staff at Georgia Cancer Specialists with office locations in Alpharetta and Center Pointe, Georgia. Georgia Cancer Specialists is a national leader in advanced cancer treatment and research. Its 50 physicians provide care in 26 Northside Hospital Cancer Institute locations across Metro Atlanta, North and Central Georgia. Both Georgia Cancer Specialists and Northside Hospital Cancer Institute recognize that patients’ journeys with cancer often begin before they set foot in the offices, and can extend long after their treatment is complete. That is why they offer “The Cancer Answer,” an integrative approach to cancer care that includes prevention, early detection, advanced treatment, clinical research, support services, and compassionate caregivers in communities across Georgia.

After earning his medical degree from St Joseph’s University Medical School, Dr. Mchayleh went on to complete his residency in internal medicine at George Washington University, followed by his fellowship in hematology and oncology at the University of Pittsburgh Medical Center. In 2016, he obtained his Master of Business Administration degree in Healthcare Management from Ohio University. 

In addition to being a Fellow of the American College of Physicians, he is a member of the American Society of Clinical Oncology, the American Medical Association, the American Society of Hematology, and the Georgia Society of Clinical Oncology. What’s more, he is board-certified in internal medicine, hematology, and medical oncology by the American Board of Internal Medicine, a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

In 2011, Dr. Mchayleh earned the Georgia Cancer Coalition Distinguished Cancer Clinician and Scientist Award, as well as multiple ASCO Merit awards. He also received specialized training in the treatment of leukemia at the University of Texas MD Anderson Cancer Center in Houston. 

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A hematologist-oncologist is a physician who specializes in the diagnosis, treatment, or prevention of blood diseases and cancers such as iron-deficiency anemia, hemophilia, sickle-cell disease, leukemia, and lymphoma. 

Recommended Articles

• Treatment Update for Hodgkin Lymphoma

  Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...

• The Lymphoma Research Foundation Announces Partnership with the Annals of Lymphoma

  The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization for lymphoma research, and they just announced their partnership with the Annals of Lymphoma (AOL). This was all revealed in September during Blood Cancer Awareness Month. LRF is devoted to exclusively funding...

• Breaking News on the Treatment of Follicular Lymphoma

  Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...

• Genetic Advancements in Lymphoma Treatment

  Cancers are a huge focus for research. Millions of dollars every year are funneled into funding research that could improve treatment methods or find cures for cancer, including blood cancers. Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin’s lymphoma (NHL) accounting...

• Living as a Hodgkin Lymphoma Survivor: Creating a New Normal

  No one can ever truly be prepared for what it is like to live with cancer. Even the strongest survivors face setbacks, and some of the fiercest warriors share their stories of how they find their "new normals."Kimberly's storyWhen she was only 25, just five days before her wedding, Kimberly felt a...

• AstraZeneca Gains United States Approval for Lymphoma Drug

  Some forms of lymphoma are rarer than others. Most people can recognize Hodgkin lymphoma, but mantle cell lymphoma will strike them as a surprise.Because it is so rare, there are not as many drugs specific to this form of cancer. One has recently been approved in the United States, by the Food and...